IN8BIO, Inc.
INAB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001740279
No open-market purchases or sales by IN8BIO, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $5.35M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in IN8BIO, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- 0 vs. Q3 2024
- Shares held
- 30.0M
- +22.4M (+293.8%) vs. Q3 2024
- Total value
- $7.72M
- +$5.66M (+275.1%) vs. Q3 2024
- New holders
- 5
- 11 more added
- Sold out
- 5
- 5 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $5.35M |
| Q1 2026 | 19 | $5.55M |
| Q4 2025 | 22 | $7.45M |
| Q3 2025 | 19 | $2.13M |
| Q2 2025 | 12 | $1.83M |
| Q1 2025 | 28 | $3.60M |
| Q4 2024 | 26 | $7.72M |
| Q3 2024 | 26 | $2.06M |
| Q2 2024 | 26 | $6.77M |
| Q1 2024 | 32 | $10.2M |
| Q4 2023 | 30 | $11.4M |
| Q3 2023 | 21 | $2.58M |
| Q2 2023 | 22 | $3.59M |
| Q1 2023 | 17 | $1.78M |
| Q4 2022 | 16 | $2.79M |
| Q3 2022 | 17 | $2.42M |
| Q2 2022 | 15 | $5.50M |
| Q1 2022 | 14 | $7.02M |
| Q4 2021 | 14 | $7.80M |
| Q3 2021 | 13 | $12.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding IN8BIO, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BIOS Capital Management, LP | 8,600,001 | $2.21M | 2.35% | +8,600,001 | New |
| AIGH Capital Management LLC | 6,191,865 | $1.59M | 0.60% | +4,517,227+269.7% | Added |
| Franklin Resources Inc | 5,696,202 | $1.47M | 0.00% | +5,696,202 | New |
| Alyeska Investment Group, L.P. | 5,063,291 | $1.30M | 0.00% | +4,628,482+1,064.5% | Added |
| Vanguard Group Inc | 1,423,897 | $365.9K | 0.00% | 00.0% | Unchanged |
| Sigma Planning Corp | 1,041,380 | $267.8K | 0.01% | +190,100+22.3% | Added |
| 683 Capital Management, LLC | 750,000 | $192.9K | 0.02% | −600,304−44.5% | Reduced |
| Geode Capital Management, LLC | 515,193 | $132.5K | 0.00% | +185,919+56.5% | Added |
| Stonegate Investment Group, LLC | 180,000 | $46.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 115,919 | $29.8K | 0.00% | +86,696+296.7% | Added |
| Northern Trust Corp | 93,420 | $24.0K | 0.00% | +63,415+211.3% | Added |
| State Street Corp | 88,746 | $22.8K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 59,572 | $15.3K | 0.00% | +356+0.6% | Added |
| UBS Group AG | 58,853 | $15.1K | 0.00% | +32,583+124.0% | Added |
| XTX Topco Ltd | 42,399 | $10.9K | 0.00% | +42,399 | New |
| Overbrook Management Corp | 33,756 | $8.68K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 21,990 | $6.00K | 0.00% | −30,817−58.4% | Reduced |
| Tower Research Capital LLC (TRC) | 18,575 | $4.77K | 0.00% | +5,386+40.8% | Added |
| LPL Financial LLC | 11,350 | $2.92K | 0.00% | −1,000−8.1% | Reduced |
| Goldman Sachs Group Inc | 10,193 | $2.62K | 0.00% | +10,193 | New |
| HighTower Advisors, LLC | 10,000 | $2.57K | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 2,000 | $514 | 0.00% | −10,000−83.3% | Reduced |
| Bank of America Corp | 460 | $118 | 0.00% | +40+9.5% | Added |
| JPMorgan Chase & Co | 112 | $29 | 0.00% | +27+31.8% | Added |
| SBI Securities Co., Ltd. | 7 | $2 | 0.00% | +7 | New |
| Rock Creek Group, LP | 1 | $0 | 0.00% | −30,293−100.0% | Reduced |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −829,176−100.0% | Sold out |
| Texas Capital Bank Wealth Management Services Inc | 0 | $0 | 0.00% | −78,624−100.0% | Sold out |
| Voss Capital, LLC | 0 | $0 | 0.00% | −64,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,252−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −102−100.0% | Sold out |